影像组学特征:术前鉴别表现为磨玻璃结节的肺浸润性腺癌的生物标志物
这项回顾性原发队列研究纳入160例经病理证实的肺腺癌,从术前平扫CT提取影像组学特征构建影像组学特征模型,并在内部交叉验证(n=76)、外部平扫CT验证(n=75)和增强CT验证(n=84)队列中评估,鉴别浸润性腺癌与非浸润性病变的准确率分别为86.3%、90.8%、84.0%和88.1%。
要点
- 影像组学特征在四个队列中鉴别浸润性腺癌与非浸润性病变的准确率为84.0%–90.8%。
- 影像组学特征是独立预测因子(OR 1.87,p < 0.001),优于CT形态学和平均CT值。
- 该特征可作为无创生物标志物辅助制定肺腺癌治疗策略。
核心结论
- 影像组学特征在鉴别浸润性腺癌与非浸润性病变方面表现出良好的预测性能,作为一种无创生物标志物,可能有助于确定肺腺癌的治疗策略。
研究设计与样本
- 回顾性原发队列研究,纳入160例经病理证实的肺腺癌,从术前非增强CT图像提取影像组学特征构建模型,并在内部交叉(n=76)、外部非增强CT(n=75)和增强CT(n=84)验证队列中评估。
诊断标准与关键数值
- 共提取355个三维影像组学特征,筛选出2个最佳鉴别特征构建影像组学特征。
- 影像组学特征鉴别浸润性腺癌与非浸润性病变的准确率在原发队列为86.3%,内部交叉验证队列为90.8%,外部非增强CT验证队列为84.0%,增强CT验证队列为88.1%。
- 调整传统术前因素后,影像组学特征仍为独立预测因子(OR 1.87,p < 0.001)。
临床应用与阅片要点
- 影像组学特征可作为无创生物标志物,辅助术前鉴别表现为磨玻璃结节的浸润性腺癌与非浸润性病变。
- 影像组学特征的独立预测能力优于CT形态学和平均CT值。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To identify the radiomics signature allowing preoperative discrimination of lung invasive adenocarcinomas from non-invasive lesions manifesting as ground-glass nodules.
METHODS: This retrospective primary cohort study included 160 pathologically confirmed lung adenocarcinomas. Radiomics features were extracted from preoperative non-contrast CT images to build a radiomics signature. The predictive performance and calibration of the radiomics signature were evaluated using intra-cross (n=76), external non-contrast-enhanced CT (n=75) and contrast-enhanced CT (n=84) validation cohorts. The performance of radiomics signature and CT morphological and quantitative indices were compared.
RESULTS: 355 three-dimensional radiomics features were extracted, and two features were identified as the best discriminators to build a radiomics signature. The radiomics signature showed a good ability to discriminate between invasive adenocarcinomas and non-invasive lesions with an accuracy of 86.3%, 90.8%, 84.0% and 88.1%, respectively, in the primary and validation cohorts. It remained an independent predictor after adjusting for traditional preoperative factors (odds ratio 1.87, p < 0.001) and demonstrated good calibration in all cohorts. It was a better independent predictor than CT morphology or mean CT value.
CONCLUSIONS: The radiomics signature showed good predictive performance in discriminating between invasive adenocarcinomas and non-invasive lesions. Being a non-invasive biomarker, it could assist in determining therapeutic strategies for lung adenocarcinoma.
KEY POINTS: • The radiomics signature was a non-invasive biomarker of lung invasive adenocarcinoma. • The radiomics signature outweighed CT morphological and quantitative indices. • A three-centre study showed that radiomics signature had good predictive performance.
引用
- Fan L, Fang M, Li Z, et al. Radiomics signature: a biomarker for the preoperative discrimination of lung invasive adenocarcinoma manifesting as a ground-glass nodule. Eur Radiol. 2018. PMID: 29967956. doi:10.1007/s00330-018-5530-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。